This tool was created to help providers understand the benefits and risks of SGLT2 inhibitors for patients with and without diabetes.
Related resource: GLP-1RA Rx Tool
Please enter all required patient information.
Made by Dr. Michael Fralick, Andy Zhao, Michelle Gyenes, and Jason Moggridge.
Funded by BioTalent Canada and Sinai Health Department of Medicine Research Fund.
© 2024. Version 1.6.0
Provide FeedbackGLP-1RA Rx Tool